Mouse anti-HLA-A0201/LMP1 for Epstein Barr VirusTechnology #2017-198-170501
Questions about this technology? Ask a Technology Manager
PRODUCT NAME HLA-A0201/LMP1 Antibody
BACKGROUND INFOMATION Epstein-Barr virus (EBV) is a gamma herpesvirus that
causes a life-long latent infection in human hosts. LMP1 is a latent gene
product expressed by EBV-associated tumors and peptide epitope derived from
this can be targeted by CD8 Cytotoxic T-Lymphocyte (CTL) lines. This antibody
allows direct visualization and quantification of its epitope in tumour tissues
and cell lines.
PRODUCT DESCRIPTION A highly specific and sensitive antibody for LMP1
epitope of the Epstein Barr Virus.
FORMAT 100µg of lyophilized, purified antibody. Reconstitute to
100µl of distilled H2O for 1µg/µl. It contains no additives.
REACTIVITY/ SPECIFICITY This antibody
was produced in mouse against LMP1 peptide YLLEMLWRL. Specific for human and
mouse. Other species not tested.
APPLICATIONS Immunofluorescence (IF), Immunohistochemistry (IHC), Western
Blot (WB), Flow Cytometry (FC)
RECOMMENDED STARTING DILUTIONS If
reconstituted in 1ml: IHC 1:500. Optimal dilution has to be determined by the
STORAGE Lyophilized antibody can be kept at 4°C for up to 3 months
and should be kept at -20°C for long-term storage. To avoid freeze-thaw cycles,
reconstituted antibody should be aliquoted before freezing for short-term
storage (-20°C) or for long-term storage (-80°C). For maximum recovery of
product, centrifuge the original vial prior to removing the cap. Further
dilutions can be made in assay buffer.
STABILITY Minimum 1 year from reception date.
REFERENCES 1. Sim, ACN., Too, CT., Oo, MZ., and Macary, PA. (2013)
Defining the expression hierarchy of latent T-cell epitopes in Epstein-Barr
virus infection with TCR-like antibodies. Nature Science Report 3. 3232, 1-5.
LIMITATIONS This product has to be used for research purposes only.